WeVote
Log In

Bill

Bill

HB 484

Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising

2026 Regular Session Introduced by Jackie Addison and 10 co-sponsors

Maryland modifies corporate income tax treatment of direct-to-consumer pharmaceutical advertising expenses, potentially affecting drug marketing practices and state tax revenue.

Hearing 2/12 at 1:00 p.m.
0
WeVote Research Nonpartisan
Bill Summary · HB 484

Legislative bill overview

HB 484 proposes to modify Maryland's corporate income tax code regarding direct-to-consumer (DTC) pharmaceutical advertising. The bill appears to create a tax modification or adjustment related to how pharmaceutical companies can deduct or treat advertising expenses when they promote medications directly to consumers rather than to healthcare providers.

Why is this important

Pharmaceutical advertising costs represent significant business expenses that affect corporate tax liability. How these costs are treated in the tax code can influence drug marketing practices, healthcare costs consumers face, and state tax revenue. The modification could either encourage or discourage DTC advertising depending on whether it allows, restricts, or conditions tax deductions for these expenses.

Potential points of contention

  • Tax revenue impact: Restricting deductions for DTC advertising could increase corporate tax revenue, but pharmaceutical companies may argue it unfairly targets their industry or reduces competitiveness
  • Healthcare costs and consumer behavior: Some advocate restricting DTC pharmaceutical advertising as it may increase drug demand and healthcare costs, while industry argues consumers have the right to information about treatment options
  • Definitional ambiguity: The bill's specific mechanism—whether it disallows deductions, creates new restrictions, or modifies existing treatment—remains unclear from available information and could determine its actual effect

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.